How a Mounjaro Prescription Works in the UK

What the trial data actually showed, and why prescribers use it

The SURMOUNT-1 trial, published in the New England Journal of Medicine, ran for 72 weeks across 2,539 adults with obesity. At the highest dose (15 mg), participants lost an average of around 20–21% of their body weight alongside lifestyle changes. That figure comes up a lot, and it is worth understanding what sits behind it: these were people eating less and moving more, not simply injecting and waiting. The prescription exists to ensure someone clinically qualified has confirmed the medicine is appropriate for you specifically, your weight, your health history, any other medicines you take, any conditions that might change the picture. A prescription is not a formality. It is the mechanism by which a clinician takes responsibility for your treatment.

The SURMOUNT-5 head-to-head trial, also published in 2025, found tirzepatide produced greater average weight reduction than semaglutide 2.4 mg over 72 weeks, a comparison that informed the NICE committee's discussion in TA1026. Citing trial data does not mean the same result is guaranteed for any individual; it means there is a serious body of evidence that informed the UK regulator's and NICE's decisions. Your prescriber will weigh that evidence against your personal clinical picture.

Who qualifies for a Mounjaro prescription in the UK

Under the licensed terms, Mounjaro is available to adults with a BMI of 30 or above, or 27 or above if they have at least one weight-related condition such as type 2 diabetes, high blood pressure, high cholesterol, or obstructive sleep apnoea. Those are the SmPC eligibility terms, the floor a prescriber works from. NICE TA1026 sets a narrower NHS threshold (BMI ≥35 with at least one comorbidity), with BMI thresholds 2.5 kg/m² lower for people of South Asian, Chinese, other Asian, Middle Eastern, Black African or African-Caribbean backgrounds.

A common misconception is that meeting the BMI number is enough to guarantee a prescription. It is not. BMI is one input. A prescriber also considers your medical history, current medications (some interact with tirzepatide's effect on gastric emptying), any contraindications listed in the summary of product characteristics, and whether your goals are realistic given how the medicine works. The number on the scale opens a door; the clinical conversation decides whether you walk through it.

For a full breakdown of what private eligibility looks like in practice, the Mounjaro treatment overview covers the criteria in plain terms.

NHS prescription versus private prescription, the practical difference

On the NHS, Mounjaro prescriptions are being rolled out in phases. From June 2025, access opened to adults with a BMI of 40 or above and four or more qualifying conditions. From around June 2026, the criteria widened to BMI 35–39.9 with four or more conditions. Future cohorts are expected to follow through to approximately March 2027. NHS prescriptions are issued through GP practices participating in the new contract, or through specialist weight management services, and participating practices vary by area, so your GP may or may not be able to prescribe yet. Access in Wales differs from England, and Scotland and Northern Ireland use separate frameworks.

A private Mounjaro prescription bypasses the waiting list and the phased cohort system. A GPhC-registered Independent Prescriber reviews your case, and if you are clinically suitable, a prescription is issued and the medicine is dispensed by a GPhC-registered pharmacy. The prescription is just as legal and just as real, it comes from a qualified clinician, not a workaround. The NHS tirzepatide medicines page sets out what the medicine is and how it works, which applies equally whether your prescription comes via the NHS or a private route.

If you want to understand what the private prescription route involves before committing to anything, this guide on getting Mounjaro on prescription walks through each step. And for an honest look at what private treatment costs, the Mounjaro cost page explains what the price includes.

What the prescription process looks like at a regulated online pharmacy

At a registered online pharmacy, the consultation is the prescription process. You answer a detailed medical questionnaire covering your weight, health conditions, current medications and relevant history. A GPhC-registered Independent Prescriber (a real clinician, not an automated system) reads your answers and makes a clinical decision. At nume, that review happens the same day. If the prescriber approves the prescription, photo-ID identity verification and live weight confirmation on video take place before the medicine is dispensed. That is not bureaucracy for its own sake; it is how a responsible prescriber confirms that the person receiving a POM is who they say they are, and that the weight data supporting the prescription is accurate.

You can verify any online pharmacy's registration on the GPhC register before you hand over any personal or medical information. A registered pharmacy's premises number will appear there. If a seller offers Mounjaro without going through a full clinical assessment, that is a serious red flag, not a shortcut, but a sign the product may not be what it claims to be. The MHRA has warned repeatedly about counterfeit weight-loss pens circulating online, some containing dangerous substances. Understanding how Mounjaro prescriptions work and what a legitimate clinical assessment involves is the clearest way to tell a safe, regulated source from one that should be avoided.

Our guide to the Mounjaro injection prescription covers the physical format, the KwikPen, how injection sites work, and what to expect when your first pen arrives. If you have questions about the prescribing process itself, our clinical team is the right place to start. When you are ready, starting your free consultation takes a few minutes and puts your case in front of a prescriber the same day.